Cargando…
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment
Current treatments for inflammatory bowel disease (IBD) treatment consist of anti-inflammatory products. In this study, we sought to induce the physiological secretion of glucagon-like peptide 2, a peptide with intestinal growth-promoting activity, via nanoparticles while simultaneously providing wi...
Autores principales: | Marotti, Valentina, Xu, Yining, Bohns Michalowski, Cécilia, Zhang, Wunan, Domingues, Inês, Ameraoui, Hafsa, Moreels, Tom G., Baatsen, Pieter, Van Hul, Matthias, Muccioli, Giulio G., Cani, Patrice D., Alhouayek, Mireille, Malfanti, Alessio, Beloqui, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582360/ https://www.ncbi.nlm.nih.gov/pubmed/37859689 http://dx.doi.org/10.1016/j.bioactmat.2023.09.014 |
Ejemplares similares
-
Exploiting the biological effect exerted by lipid nanocapsules in non-alcoholic fatty liver disease
por: Domingues, Inês, et al.
Publicado: (2023) -
Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment
por: Zhang, Wunan, et al.
Publicado: (2021) -
High-fat diet feeding differentially affects the development of inflammation in the central nervous system
por: Guillemot-Legris, Owein, et al.
Publicado: (2016) -
Dysosmobacter welbionis effects on glucose, lipid, and energy metabolism are associated with specific bioactive lipids
por: Moens de Hase, Emilie, et al.
Publicado: (2023) -
Novel strategy for oral peptide delivery in incretin-based diabetes treatment
por: Xu, Yining, et al.
Publicado: (2020)